Biological model of ED01 hepatocarcinogenesis

Toxicology and Applied Pharmacology

Volumn 140, Issue 1, 1996, Pages 19-29

  Travis, Curtis C ^a   Zeng, Chenxin ^a,b   Nicholas, Joyce ^a,c  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N (2 FLUORENYL)ACETAMIDE;

ANIMAL MODEL; ARTICLE; BIOASSAY; BIOLOGICAL MODEL; CELL PROLIFERATION; CELL TRANSFORMATION; COMPUTER SIMULATION; FEMALE; GENOTOXICITY; LIVER CARCINOGENESIS; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0030245588     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0193     Document Type: Article

References (34)

1. Asamoto, M., Tsuda, H., Kato, T., Ito, N., Masuko, T., Hashimoto, Y., and Nagase, S. (1989). Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: Immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-Acetylaminofluorene and phenobarbital. Jpn. J. Cancer Res. 80, 1041-1046.
2. Beland, F. A., Fullerton, N. F., Kinouchi, T., and Poirier, M. C. (1988). DNA Adduct Formation during Continuous Feeding of 2-Acetylaminofluorene at Multiple Concentrations, Vol. 89, pp. 175-180. IARC Scientific Publications.
3. Cairns, T. (1979). The ED01 study: Introduction, objectives, and experimental design. J. Environ. Pathol. Toxicol. 3(3), 1-8.
4. Cha, R., Thilly, W. G., and Zarbl, H. (1994). N-nitros-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutation. Proc. Natl. Acad. Sci. USA 91, 3749-3753.
5. Chen, B., Liu, B., Castonguay, A., Maronpot, R. R., Anderson, M. W., and You, M. (1993). Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridy)-1-butanone induced mouse lung tumors. Carcinogenesis 14, 1603-1608.
6. Cohen, S. M., and Ellwein, L. B. (1990). Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: Biological modeling of the ED01 study. Toxicol. Appl. Pharmacol 104, 79-93.
7. Conolly, R. B., and Kimbell, J. S. (1994). Computer simulation of cell growth governed by stochastic processes: Application to clonal growth cancer models. Toxicol. Appl. Pharmacol. 124, 284-295.
8. Counts, J. L., and Goodman, J. I. (1994). Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion. Mol. Carcinog. 11, 185-188.
9. Counts, J. L., and Goodman, J. I. (1995). Alteration in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, 13-15.
10. Dees, H. C., and Travis, C. C. (1994). Hyperphosphorylation of p53 induced by benzene, toluene and chlorophorm. Cancer Lett. 84, 117-123.
11. Farmar, J. H., Kodell, R. L., and Greenman, D. L. (1979). Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol. 3, 55-68.
12. Gaylor, D. W. (1979). The ED01 study: Summary and conclusions. J. Environ. Pathol. Toxicol. 3, 179-186.
13. Gold, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., Veciana, M. de, Levinson, L., Peto, R., Pike, M. C., and Ames, B. N. (1984). A carcinogenic potency database of the standardized results of animal bioassays. Environ. Health Perspect. 58, 9-319.
14. Goldworthy, T. L., Hanigna, M. H., and Pilot, H. C. (1986). Models of hepatocarcinogenesis in the rat - Contrasts and comparisons. CRC Crit. Rev. Toxicol. 17, 61-89.
15. Ito, N., Tatematsu, M., Nakanishi, K., Hasegawa, R., Takano, T., Imaida, K., and Ogiso, T. (1980). The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gann 71, 832-842.
16. Kraup-Grasl, B., Huber, W., Taper, H., and Schulte-Herman, R. (1991). Increase susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res. 51, 666-671.
17. Littlefield, N. A., Farmer, J. H., Gaylor, D. W., and Sheldon, W. G. (1979). Effects of dose and time in a long-term, low-dose carcinogenic study. J. Environ. Pathol. Toxicol. 3(3), 17-34.
18. Moolgavkar, S. H., and Venzen, D. (1979). Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Math. Biosci. 47, 55-77.
19. Moolgavkar, S. H., Day, N. E., and Stevens, R. G. (1980). Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J. Natl. Cancer Inst. 65(3), 559-569.
20. Moolgavkar, S. H., Dewanji, A., and Venzon, D. J. (1988). A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor. Risk Anal. 8, 383-392.
21. Moulds, B. A., and Goodman, J. I. (1994). Spontaneous mutation of codon 61 of the Ha-ras gene in the nascent liver of B6C3F1, C3H/He and C67BL/6 mice. Mutat. Res. 311, 1-7.
22. Poirier, M. C., and Beland, F. A. (1992). DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA adduct-based human cancer risk assessment. Chem. Rex. Toxicol. 5, 749-755.
23. Poirier, M. C., Fullerton, N. F., Kinouchi, T., Smith, B. A., and Beland, F. A. (1991). Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis 12(5), 895-900.
24. Rajewsky, M. F., Dauber, W., and Frankenberg, H. (1966). Liver carcinogenesis by diethylnitrosamine in the Rat. Science 152, 83-85.
25. Swenberg, J. A., Richardson, F. C., Boucheron, J. A., Deal, F. H., Belinsky, S. A., Charbonneau, M., and Short, B. G. (1987). High-to-low dose extrapolation: Critical determinants involved in the dose response of carcinogenic substances. Environ. Health Perspect. 76, 57-63.
26. Tatematsu, M., Aoki, T., Kagawa, M., Mera, Y., and Ito, N. (1988). Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis 9, 221-225.
27. Tiwawech, D., Hasegawa, R., Kurata, Y., Tatematsu, M., Shibata, M. A., Thamavit, W., and Ito, N. (1991). Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis 12, 985-990.
28. Travis, C. C., and Arms, A. D. (1990). Reference Physiological Parameters for Pharmacodynamic Modeling of Liver Cancer. Document prepared at the Office of Risk Analysis, Health and Safety Research Division, Oak Ridge National Laboratory, Oak Ridge, TN.
29. Travis, C. C., and Birkner, P. D. (1991). Druckery slope controlled by mitotic rate of enzymatically-altered foci. J. Theor. Biol. 149, 217-227.
30. Travis, C. C., McClain, T. W., and Birkner, P. D. (1991). Diethylnitrosamine-induced hepatocarcinogenesis in rats: A theoretical study. Toxicol. Appl. Pharmacol. 109, 289-304.
31. Trosko, J. E., and Chang, C. C. (1988). Nongenotoxic mechanisms in carcinogenesis: Role of inhibited intercellular communication. In Carcinogen Risk Assessment: New Directions in the Qualitative and Quantitative Aspects (R. W. Hart and F. D. Hoerger, Eds.), pp. 139-170. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
32. Umemura, T., Tokumo, K., Sirma, H., Gebhardt, R., Poirier, M., and Williams, G. (1993). Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett. 73, 1-10.
33. Xu, Y., Campbell, H. A., Sattler, G. L., Hendrich, S., Maronpot, R., Sato, K., and Pilot, H. C. (1990). Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Cancer Res. 50, 472-479.
34. Zhang, R., Haag, J. D., and Gould, N. (1990). Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea does or increasing prolactin levels. Cancer Res. 50, 4286-4290.